ePRO IN ONCOLOGY: PATIENT PREFERENCE, COMPLIANCE, & BEST PRACTICES
ePRO IN ONCOLOGY: PATIENT PREFERENCE, COMPLIANCE, & BEST PRACTICES
6 PagesePRO IS BECOMING INCREASINGLY IMPORTANT IN CANCER TRIALS ONCOLOGY PATIENT PREFERENCE Patient-reported outcomes (PROs) and electronic PRO (ePRO) are increasingly becoming an important aspect of cancer clinical trials and patient care, especially with regard to measuring drug efficacy, patient quality of life, and drug safety. Several studies have found that oncology patients find electronic handheld diaries and tablets easy to use, helpful, and preferable over paper, thus alleviating any concern as to whether patient burden, health status, or age impact the feasibility of using ePRO with oncology patients. > Oncology patients think that electronic symptoms reporting positively impacts their clinical care. 87% of patients think that symptom assessments are important to complete b
